| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |